ATE270889T1 - Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung - Google Patents
Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischungInfo
- Publication number
- ATE270889T1 ATE270889T1 AT98944376T AT98944376T ATE270889T1 AT E270889 T1 ATE270889 T1 AT E270889T1 AT 98944376 T AT98944376 T AT 98944376T AT 98944376 T AT98944376 T AT 98944376T AT E270889 T1 ATE270889 T1 AT E270889T1
- Authority
- AT
- Austria
- Prior art keywords
- monoamin
- mixture containing
- partial agonist
- oxidase inhibitor
- beta antagonist
- Prior art date
Links
- 239000002876 beta blocker Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
- 239000004031 partial agonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703376A SE9703376D0 (sv) | 1997-09-18 | 1997-09-18 | A new combination |
| PCT/SE1998/001602 WO1999013878A1 (en) | 1997-09-18 | 1998-09-09 | A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270889T1 true ATE270889T1 (de) | 2004-07-15 |
Family
ID=20408296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98944376T ATE270889T1 (de) | 1997-09-18 | 1998-09-09 | Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6159970A (https=) |
| EP (1) | EP1014986B1 (https=) |
| JP (1) | JP2001516719A (https=) |
| KR (2) | KR20010024084A (https=) |
| CN (1) | CN1278727A (https=) |
| AR (1) | AR013503A1 (https=) |
| AT (1) | ATE270889T1 (https=) |
| AU (1) | AU752719B2 (https=) |
| BR (1) | BR9812236A (https=) |
| CA (1) | CA2302204A1 (https=) |
| DE (1) | DE69825062T2 (https=) |
| DK (1) | DK1014986T3 (https=) |
| EE (1) | EE200000146A (https=) |
| ES (1) | ES2222603T3 (https=) |
| HU (1) | HUP0100621A2 (https=) |
| ID (1) | ID25789A (https=) |
| IL (1) | IL134775A0 (https=) |
| IS (1) | IS5401A (https=) |
| MX (1) | MXPA00002616A (https=) |
| NO (1) | NO20001400L (https=) |
| PL (1) | PL339368A1 (https=) |
| PT (1) | PT1014986E (https=) |
| SE (1) | SE9703376D0 (https=) |
| SK (1) | SK2832000A3 (https=) |
| TR (1) | TR200000725T2 (https=) |
| WO (1) | WO1999013878A1 (https=) |
| ZA (1) | ZA987804B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957948A (en) * | 1988-05-05 | 1990-09-18 | Interface, Inc. | Biocidal protective coating for heat exchanger coils |
| SE9601110D0 (sv) | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| WO2002066454A1 (fr) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Derives de chromene |
| ATE424825T1 (de) * | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US20090054453A1 (en) * | 2006-03-17 | 2009-02-26 | Lilian Alcaraz | Novel Tetralins as 5-HT6 Modulators |
| EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2008220785B2 (en) | 2007-03-01 | 2013-02-21 | Vivoryon Therapeutics N.V. | New use of glutaminyl cyclase inhibitors |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤 |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
| CN110179988A (zh) * | 2019-07-10 | 2019-08-30 | 王大伟 | 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用 |
| WO2024130044A1 (en) * | 2022-12-14 | 2024-06-20 | Luminous Mind Inc. | Treatment of psychological factors affecting other medical conditions (pfaomc) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| PT533268E (pt) * | 1991-09-18 | 2002-02-28 | Glaxo Group Ltd | Derivados de benzanilida como antagonistas de 5-ht1d |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-09-18 SE SE9703376A patent/SE9703376D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987804A patent/ZA987804B/xx unknown
- 1998-09-09 CA CA002302204A patent/CA2302204A1/en not_active Abandoned
- 1998-09-09 MX MXPA00002616A patent/MXPA00002616A/es unknown
- 1998-09-09 HU HU0100621A patent/HUP0100621A2/hu unknown
- 1998-09-09 AU AU91931/98A patent/AU752719B2/en not_active Ceased
- 1998-09-09 EP EP98944376A patent/EP1014986B1/en not_active Expired - Lifetime
- 1998-09-09 TR TR2000/00725T patent/TR200000725T2/xx unknown
- 1998-09-09 BR BR9812236-3A patent/BR9812236A/pt not_active IP Right Cessation
- 1998-09-09 PL PL98339368A patent/PL339368A1/xx unknown
- 1998-09-09 WO PCT/SE1998/001602 patent/WO1999013878A1/en not_active Ceased
- 1998-09-09 SK SK283-2000A patent/SK2832000A3/sk unknown
- 1998-09-09 AT AT98944376T patent/ATE270889T1/de not_active IP Right Cessation
- 1998-09-09 CN CN98811114A patent/CN1278727A/zh active Pending
- 1998-09-09 KR KR1020007002830A patent/KR20010024084A/ko not_active Withdrawn
- 1998-09-09 ES ES98944376T patent/ES2222603T3/es not_active Expired - Lifetime
- 1998-09-09 ID IDW20000522D patent/ID25789A/id unknown
- 1998-09-09 US US09/171,578 patent/US6159970A/en not_active Expired - Fee Related
- 1998-09-09 DE DE69825062T patent/DE69825062T2/de not_active Expired - Fee Related
- 1998-09-09 PT PT98944376T patent/PT1014986E/pt unknown
- 1998-09-09 EE EEP200000146A patent/EE200000146A/xx unknown
- 1998-09-09 KR KR1020007002835A patent/KR20010024087A/ko not_active Ceased
- 1998-09-09 DK DK98944376T patent/DK1014986T3/da active
- 1998-09-09 JP JP2000511500A patent/JP2001516719A/ja active Pending
- 1998-09-09 IL IL13477598A patent/IL134775A0/xx unknown
- 1998-09-17 AR ARP980104635A patent/AR013503A1/es unknown
-
2000
- 2000-03-14 IS IS5401A patent/IS5401A/is unknown
- 2000-03-17 NO NO20001400A patent/NO20001400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IS5401A (is) | 2000-03-14 |
| EE200000146A (et) | 2001-02-15 |
| ES2222603T3 (es) | 2005-02-01 |
| DE69825062T2 (de) | 2005-08-25 |
| EP1014986B1 (en) | 2004-07-14 |
| DK1014986T3 (da) | 2004-10-25 |
| KR20010024084A (ko) | 2001-03-26 |
| HUP0100621A2 (hu) | 2001-08-28 |
| AU752719B2 (en) | 2002-09-26 |
| BR9812236A (pt) | 2000-07-18 |
| ZA987804B (en) | 1999-03-18 |
| NO20001400D0 (no) | 2000-03-17 |
| KR20010024087A (ko) | 2001-03-26 |
| PT1014986E (pt) | 2004-10-29 |
| CA2302204A1 (en) | 1999-03-25 |
| SE9703376D0 (sv) | 1997-09-18 |
| EP1014986A1 (en) | 2000-07-05 |
| IL134775A0 (en) | 2001-04-30 |
| AU9193198A (en) | 1999-04-05 |
| TR200000725T2 (tr) | 2000-08-21 |
| JP2001516719A (ja) | 2001-10-02 |
| WO1999013878A1 (en) | 1999-03-25 |
| PL339368A1 (en) | 2000-12-18 |
| US6159970A (en) | 2000-12-12 |
| DE69825062D1 (de) | 2004-08-19 |
| AR013503A1 (es) | 2000-12-27 |
| ID25789A (id) | 2000-11-02 |
| MXPA00002616A (es) | 2002-04-24 |
| CN1278727A (zh) | 2001-01-03 |
| NO20001400L (no) | 2000-05-05 |
| SK2832000A3 (en) | 2000-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE270889T1 (de) | Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung | |
| FI943745L (fi) | Koostumuksia ja menetelmiä proteiinin rakenteen määrityksiin | |
| ID17316A (id) | Komposisi aditif untuk pembawa bahan bermanfaat dan komposisi batang yang mengandung aditif tersebut | |
| FI944310A7 (fi) | Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä | |
| BR9707501A (pt) | Composto composição farmacêutica e uso do composto | |
| PL339371A1 (en) | Composition containing 5-ht reuptake inhibitor and antagonist or partial agonist of h5-ht 1b | |
| FI970317A7 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| ZA985096B (en) | Composition compound and use | |
| HUP9801227A3 (en) | Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use | |
| DE69620642D1 (de) | Reiningungsverfahren und-zusammensetzung | |
| EP1069901A4 (en) | CALCILYTIC COMPOUNDS AND THEIR USE | |
| HUP0003039A3 (en) | Synergistic fungicidal mixture and use thereof | |
| HUP9901320A3 (en) | Synergistic herbicidal composition and method of use thereof | |
| EG21286A (en) | Blends of organosillane compounds and their use | |
| BR9612413A (pt) | Composto uso do mesmo e composição farmacêutica | |
| BR9711684A (pt) | Composi-Æo para gaxeta e gaxeta | |
| PT826679E (pt) | Compostos de naftilo intermediarios composicoes e metodos de utilizacao | |
| FI102031B1 (fi) | Rehulisäjauhekoostumus ja sen käyttö | |
| PL339370A1 (en) | Composition containing selective antagonist of 5-ht 1a and selective antagonist or partial agonist of h5-ht 1b | |
| BR9807696B1 (pt) | método para eliminação de ervas daninhas e uso de uma mistura. | |
| HUP0002791A3 (en) | Synergistic fungicidal mixture and use thereof | |
| BR9510407A (pt) | Composição fotopolimerizável com acetilenos e processos para a fotopolimerização de acetilenos | |
| NO972216D0 (no) | Acrotein-frigjörende sammensetning og dens anvendelse | |
| FI970318L (fi) | Antiproliferatiivisina aineina ja Garft-inhibiitoreina käyttökelpoisia yhdisteitä | |
| HK1032738A (en) | A combination of a monoamine oxidase inhibitor and a h5-ht 1 beta antagonist or partial agonist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1014986 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |